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S U M M A R Y
Background: On September 22, 2013, two patients from Sichuan Province, China presented with
symptoms of food-borne botulism, a rare but fatal illness caused by the consumption of foods containing
Clostridium botulinum neurotoxins.
Methods: Investigators reviewed the medical charts and food consumption histories, and interviewed
patients and family members. Food samples and clinical specimens were tested for botulinum toxin and
neurotoxin-producing Clostridium species by standard methods.
Results: The ﬁrst two index cases presented with cranial neuropathies and ﬂaccid paralysis, and required
mechanical ventilation. There were 12 conﬁrmed outbreak-associated cases. Botulinum toxin type A was
identiﬁed in the smoked ribs, and all of the patients had consumed the smoked ribs from the same local
restaurant. The smoked ribs contained no added salt, sugar, or preservative. Botulinum toxin production
likely resulted from the cold-smoking preparation method and inappropriate refrigeration.
Conclusions: Smoked ribs produced by a local restaurant, contaminated with type A botulism, was the
contributor to this outbreak. The supervision of food safety should be strengthened to prevent future
outbreaks in China.
 2014 International Society for Infectious Diseases. Published by Elsevier Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Botulism is an acute life-threatening neurological disorder
caused by the neurotoxin of Clostridium botulinum. Botulinum
neurotoxins (BoNTs) are considered the most toxic substances
currently known.1 BoNTs have traditionally been categorized into
seven serotypes – BoNT/A to BoNT/G – and BoNTs A, B, E, and
more rarely F, are known to cause botulism in humans.2
Food-borne botulism is caused by the consumption of food
containing a BoNT produced by the bacterium C. botulinum. The
spores of these bacteria are dormant in the environment, but
germination and toxin production occur under anaerobic, low
sugar, and low salt conditions at non-refrigeration temperatures
(temperatures >10 8C for most strains).3,4 Food-borne botulism
can arise from home-canned foods with a low acid content, such
as carrot juice, green beans, and corn. Therefore, low-acid foods
should be boiled before consumption.
BoNTs bind irreversibly to the presynaptic nerve endings and
inhibit the release of acetylcholine, resulting in symmetric cranial* Corresponding author. Fax: +86 028 85423550.
E-mail address: 441607140@qq.com (R. Yang).
1 Both authors contributed equally to the work.
http://dx.doi.org/10.1016/j.ijid.2014.10.008
1201-9712/ 2014 International Society for Infectious Diseases. Published by Elsev
creativecommons.org/licenses/by-nc-nd/3.0/).nerve palsy and secondary symmetric descending ﬂaccid paralysis,
which may progress to respiratory arrest.5,6 Clinical symptoms
of botulism appear after an incubation period and vary greatly
according to the serotype and degree of exposure to the toxin.7 The
death rate among patients with botulism is 3–10%.4,8,9
Here we describe an outbreak of food-borne botulism affecting
12 people in two families; the outbreak occurred on September
22–23, 2013 in Sichuan Province, China. Clinicians immediately
took proper therapeutic measures and notiﬁed the public health
ofﬁcials. An epidemiological investigation was initiated to identify
persons exposed to the implicated product and to collect clinical
specimens and food samples for laboratory testing. The epidemio-
logical and microbiological investigations showed that smoked
ribs made in the same local restaurant were the only source of
the outbreak.
2. Methods
2.1. Epidemiological investigation
We interviewed the ﬁrst two patients and their families and
reviewed their contacts with regard to food exposure to common
items. We deﬁned a case as illness in a patient with any objectiveier Ltd. This is an open access article under the CC BY-NC-ND license (http://
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sumed the smoked ribs in the local restaurant before illness onset.
A conﬁrmed outbreak-associated case had to meet one of the
following three criteria: (1) A clinically diagnosed patient with
laboratory-conﬁrmed botulism (BoNT and/or C. botulinum identi-
ﬁed in a clinical specimen), known to have consumed the
implicated product; the remnants of the product were contami-
nated with BoNT. (2) A patient with laboratory-conﬁrmed
botulism who was reported to have consumed the implicated
product. (3) A patient with clinically-diagnosed botulism who was
reported to have consumed the implicated product.
2.2. Traceback and investigation of the smoked ribs
The smoked ribs were identiﬁed as the sole food item that all
patients reported having eaten. Investigators examined the
kitchen equipment, interviewed the chef about how much they
were processed, and collected food samples for testing.
2.3. Laboratory investigation
Clinical specimens were tested by the Academy of Military
Medical Sciences in Beijing, China, which has developed immuno-
colloidal gold kits to screen serum and stool specimens for BoNT
type A.10 First, a colloidal gold solution was prepared by constant
mixing of 0.01% (w/v) chloroauric acid hydrate (gold chloride) and
0.01% (w/v) sodium citrate for about 10 min at boiling tempera-
ture. The pH of the solution was then titrated to 8.5 with
K2CO3. Next, anti-BoNT-type A antibody was dialyzed and added to
the colloidal gold solution. The antibody was labeled with colloidal
gold after incubation for 30 min at room temperature (RT). Bovine
serum albumin (BSA; 2% (w/v)) was added, and the solution was
incubated for 15 min at RT. To remove large debris, the solution
was centrifuged for 10 min at 500 g, and to enrich the labeled
probe, another centrifugation was performed (6000 g, 20 min). The
probe was then re-suspended in blocking solution (1% (w/v) BSA in
phosphate buffered saline (PBS) (pH 7.4). Test strips were
constructed for BoNT type A detection using instruments
HGS201 and HGS101 (JN-Bio, Shanghai, China), in accordance
with the manufacturer’s protocol. Stool specimens were cultured
anaerobically for the isolation of C. botulinum by use of standard
culture techniques.11,12 Patient serum specimens, stool specimens,
and the smoked ribs were examined for BoNT according to the
study protocol approved by the Human Research Ethics Committee
of West China Hospital of Sichuan University; all participants gave
their written informed consent.
3. Results
3.1. Descriptive epidemiology and clinical ﬁndings
A total of 12 cases were considered as suspected outbreak-
associated cases. On September 22, 2013, the ﬁrst two patients
were admitted to West China Hospital of Sichuan University with
similar symptoms of diplopia, ptosis, dizziness, dysphagia, and
dysarthria, preceded by gastrointestinal symptoms. One day after
hospital admission, the conditions of these patients deteriorated
rapidly. Food-borne botulism was suspected based on clinical
manifestations. During interviews, it was found that they came
from the same household and had consumed smoked ribs in a local
restaurant on September 21, 26 h before illness onset. During days
1 and 2 of hospitalization, descending paralysis progressed quickly
to quadriplegia and respiratory arrest, requiring intubation and
mechanical ventilation. On September 23, 1 day after the index
cases were hospitalized, ﬁve patients from the same household
also exhibited signs and symptoms of botulism; the ocular muscleswere affected, followed by dysarthria progressing to muscle
weakness. These patients, together with the ﬁrst two patients, had
consumed a meal on September 21 that included the smoked ribs.
The ﬁve patients from family 2 had illness onset on September
23, 2013. They had consumed a dinner together in the same local
restaurant on September 21. Similar to the patients from family 1,
they had ordered the smoked ribs. They were admitted to the
country hospital. The symptoms reported by the ﬁve patients were
dry mouth, feeling of a ‘thick tongue’, tiredness, dysarthria,
dysphagia, diplopia, ptosis, and subjective muscle weakness.
Although their clinical symptoms matched with botulism, the
doctors of the country hospital did not recognize a suspected
botulism outbreak at that time. Due to the restriction of medical
condition, botulism anti-toxin A was not administered to these
patients in the country hospital. On October 1, all ﬁve patients
were transferred to the West China Hospital of Sichuan University
for further treatment. Botulism anti-toxin A was administered
based on the patients’ clinical manifestations in combination with
the epidemiological connection, without waiting for laboratory
conﬁrmation.
The date of illness onset ranged from September 22 to 23. The
median age of the patients was 37 years (range 4–61 years); six
(50%) were male and six were female. All 12 patients were
admitted to hospital and treated with 100 000 units of botulism
anti-toxin A by intravenous drip. Botulism anti-toxin A was
administered immediately when a patient was suspected to have
botulism. Bowel cleaning therapy, including enemas with 5%
sodium bicarbonate, was also given. The median duration of
hospitalization was 8 days (range 5–19 days). Two patients from
the ﬁrst family had severe paralysis, and mechanical ventilation
support was required; however no deaths occurred. Patients
presented the following neurological symptoms: blurred vision
(50% of patients), diplopia (41.7%), ptosis (58.3%), dysphonia (50%),
dysphagia (50%), and muscle weakness (75%). Patients also
exhibited varying degrees of gastrointestinal symptoms, including
nausea (25%), abdominal pain (8.3%), vomiting (16.7%), and
diarrhea (8.3%). Two patients from the ﬁrst family experienced
predominantly gastrointestinal symptoms of nausea and vomiting,
which preceded the neurological symptoms (Table 1).
3.2. Laboratory investigation
Serum and stool specimens from all 12 patients were examined.
For the seven patients from family 1, BoNT type A was identiﬁed in
serum samples collected 2 days after illness onset by use of
immuno-colloidal gold kits. BoNT type A was also identiﬁed in four
stool samples and conﬁrmed as type A by ELISA; C. botulinum
strains were isolated and identiﬁed using standard culture
techniques. For the ﬁve patients from family 2, four serum
samples tested positive for BoNT type A and one serum sample,
collected 3 days after admission to the country hospital, tested
negative. Stool specimens collected on days 3 and 4 were negative
for BoNT and no neurotoxin-producing C. botulinum strains were
isolated.
The local public health team carried out an intensive
investigation including a comprehensive food consumption
history. The smoked ribs had been served by a local restaurant
during a family meal 2 days before the ﬁrst two patients were
admitted to hospital. The smoked ribs had been eaten by the ﬁrst
two patients who were placed on respiratory support, and had
been tasted by the other patients from the household. The ﬁve
patients from the second family had also consumed the smoked
ribs in the same restaurant on the same day. BoNT type A was
identiﬁed in the smoked ribs obtained from the refrigerator of the
local restaurant. C. botulinum strains from the food samples were
isolated and then veriﬁed as type A.
Table 1
Demographic characteristics, time intervals between key clinical events, and clinical outcomes of patients who consumed the smoked ribs
Group 1 Group 2 Group 3
Patient Patients 1 and 2 from family 1 Patients 3, 4, 5, 6, and
7 from family 1
Patients 8, 9, 10, 11 and
12 from family 2
Date of consumption September 21, 2013 September 21, 2013 September 21, 2013
Date of symptom onset September 22, 2013 September 23, 2013 September 23, 2013
Public health ofﬁcials notiﬁed September 22, 2013 September 23, 2013 October 1, 2013
Symptom onset to anti-toxin treatment 22 h 16 h 186 h
Clinical severity Required mechanical ventilation
support
Hospitalized Hospitalized
Symptom onset to intubation 26 h for patient 1
78 h for patient 2
- -
Duration of intubation 12 days for patient 1
9 days for patient 2
- -
Clinical outcome 6 months
after symptom onset
Rehabilitation facility, not
ventilator-dependent
Fully recovered Fully recovered
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On October 8, 2013, the restaurant was temporarily closed to
cooperate with the investigations into the process of producing the
smoked ribs. In brief, the process used was as follows: First, the
cure mixtures were prepared, which contained salts, sugar, and
spices. Usually, 1 g salt was used for 0.4 kilograms of ribs and the
mixture was rubbed all over the ribs. The salt-rubbed ribs were
then transferred to a large bag and placed in the refrigerator for
5 days. Next, the ribs were removed from the bag 5 days later,
rinsed thoroughly under cold water, and dried on a towel
uncovered in the refrigerator overnight. Following this ‘cold
smoking’ was done over a smoldering ﬁre (below 85 8C) for 12–
24 h. Finally, the ribs were cooled in the refrigerator overnight
before serving. The sterile cubicle used to sterilize containers of the
implicated products showed signs of improper operation and
maintenance. Additionally, the smoked ribs were usually stored at
room temperature. However, there was no ﬁrm indication of how
the smoked ribs had become contaminated.
All of the implicated products that were still in the restaurant
were withdrawn by the local authorities, and the restaurant helped
to identify consumers who had eaten the smoked ribs. The
implicated product was reported in a press release accompanied by
a photograph of the smoked ribs. Warnings were issued to the
public and to the medical institutions about the clinical symptoms
of botulism. Emergency procedures were put in place to ensure
that physicians could obtain botulism anti-toxin A if required.
4. Discussion
Food-borne botulism has mainly occurred in the northern areas
of China, particularly in Hebei Province10 and the Qinghai–Tibet
plateau.13 It has rarely been reported in the southwest of China,
including Sichuan Province. The outbreak discussed here was the
ﬁrst report of C. botulinum linked with smoked ribs in China.
Botulism is an acute paralytic disease caused by a neurotoxin
produced by an anaerobic bacterium, Clostridium botulinum. Food-
borne botulism occurs when food containing BoNT is eaten. BoNT
is produced in contaminated food before digestion, and the
food has usually been subject to inadequate cooking, poor
production hygiene, and improper storage.14 Because the smoked
ribs contaminated with C. botulinum type A accounted for this
outbreak, we assumed that there was a failure to maintain a
temperature below 10 8C. The smoked ribs were prepared and
stored at room temperature, which may have provided the
conditions required for the growth of C. botulinum and for toxin
production.15 BoNT production may have occurred due to
incorrect handling, for example no acidifying preservative, salt,or sugars were added to the smoked ribs, and also the duration
and temperature of the smoking process were inadequate to kill
the spores. Heating for 30 min at 121 8C is required to kill the
spores, and BoNT can be decomposed by boiling or heating to 80 8C
for 10 min. In accordance with the guidelines of the US Food and
Drug Administration (FDA), the cold-smoking method is not
recommended by most food scientists because of the inherent
risks, since rapid microbial growth can occur in the temperature
zone used (40–140 8C). Additionally, the cold-smoked foods
should be cooked to an internal temperature of 160 8C before
they are eaten.
It is important to keep in mind that food-borne botulinum is
still a very real possibility, with serious results.16Many physicians
are unfamiliar with the disease in China, and disease symptoms
can easily be confused with those of other more common illnesses.
Even in this outbreak, a mistaken preliminary diagnosis was
made; the index cases were ﬁrst diagnosed as myasthenia
gravis. Other causes of ﬂaccid paralysis must be excluded.11 An
incremental response to repetitive stimulation in electrophysio-
logical studies may be helpful in distinguishing botulism from
myasthenia gravis.17 Further, computed tomography scans are
useful to identify a space-occupying lesion, cerebrospinal ﬂuid
(CSF) ﬁndings can help to identify infections of the central nervous
system, and CSF protein is usually increased in Guillain–Barre´
syndrome but normal in botulism.18
The incubation period for the ﬁrst family was 32 h after
exposure and the incubation period for the second family was
2 days. These ﬁndings are consistent with previously reported
botulism case descriptions, and the median incubation period
for patients with type A botulism is usually 12–36 h following
the consumption of BoNT.18,19 However, the longest incubation
period reported is 12 days.20–22 In addition, the ﬁrst two index
cases were characterized by rapid onset and protracted paralysis.
These two patients had consumed large amounts of the
smoked ribs according to the detailed history-taking. This may
explain the rapid progression and requirement for mechanical
ventilation.
Prompt anti-toxin therapy is particularly important for these
patients. The administration of botulinum anti-toxin is the only
speciﬁc treatment for botulism, and anti-toxin should be given to
patients as soon as possible after clinical diagnosis, ideally at <24 h
after the onset of symptoms. Normally, if anti-toxin is given at
>3 days after the onset of symptoms, it is less likely to be of
beneﬁt, and anti-toxin is not given if a patient is identiﬁed with
neurological symptoms consistent with botulism at >7 days after
disease onset and if symptoms are not progressing. However, it
has been reported that the administration of anti-toxin 11 days
after exposure to contaminated food is helpful for patients with
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toxemic 13 days and 46 days, respectively, after the onset of
symptoms, and their conditions improved with anti-toxin
treatment.24 In this outbreak, all patients were treated with
100 000 units of botulism anti-toxin A. We take the following
factors into consideration: toxemia may occur for 7 days after
symptom onset and the patients may have consumed a high
dose of toxin. Before receiving anti-toxin, patients should take an
allergy test for sensitivity. In our cases, the skin test was positive
in one patient who was severely paralyzed and dependent on
respiratory support. This patient was desensitized over several
hours before the full dose of anti-toxin was administered and no
allergic reactions were observed during the entire treatment.
The timing of sample collection is important as the sensitivity of
detection decreases rapidly with time. BoNT is detected in <25% of
serum specimens obtained after 3 days25 and <20% of serum
samples taken after 6 days.2 In this outbreak, BoNT type A was
detected in all serum samples collected 2 days after illness onset for
the ﬁrst family. For the second family, clinical specimens were
obtained and refrigerated by the country hospital; these were
submitted to the botulism laboratory for the speciﬁc diagnosis and
conﬁrmation of botulism after the botulism outbreak was suspected.
BoNT type A was present in the serum samples of four of these
patients, obtained 5 days after toxin consumption. Although the
persistence of BoNT in the bloodstream has been reported at
25 days after symptom onset,24 ingested BoNT is normally not
demonstrable in serum at 1 week after ingestion.26 Stool specimens
collected 6 days after toxin consumption from these four patients
with toxemia were negative for BoNT and did not contain
C. botulinum, suggesting that there was no in vivo toxin production
due to an intestinal colonization. Issues that need to be considered
are that only 36% of stool samples are positive for BoNT after
3 days,27 and C. botulinum is present in stool samples of >70%
patients within 2 days and 40% after 10 days.25 In addition, some
patients in the ﬁrst family presented gastrointestinal symptoms
initially, including diarrhea, vomiting, nausea, and abdominal pain,
and this phenomenon may partly explain why only four out of
seven patients in the ﬁrst family had stool samples positive for
BoNT type A.
With the help of the local health authority, the Centers for
Disease Control and Prevention, and the National Health and
Family Planning Commission, the response to this outbreak was
timely. Even though botulism is a rare disease, it should be
considered in every patient with neuromuscular deﬁcits who has a
history of suspicious food consumption. Profound, protracted
paralysis may be associated with the consumption of high levels of
toxin, and timely and sufﬁcient anti-toxin treatment is required.
This outbreak of botulism suggests that the supervision of food
safety should be strengthened in China to avoid this potentially
severe health hazard.
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